The global veterinary point of care diagnostics market size was valued at USD 2.3 billion in 2025 and is projected to grow from USD 2.51 billion in 2026 to USD 5.13 billion by 2034, registering a CAGR of 9.32% during the forecast period from 2026 to 2034. North America dominated the veterinary point of care diagnostics market with a market share of 40.5% in 2025.
Veterinary point-of-care diagnostics are diagnostic tests and devices used to detect, monitor, and evaluate diseases and health conditions in animals directly at veterinary clinics, hospitals, farms, and other care settings. These solutions provide rapid results from samples such as blood, urine, and other biological fluids, supporting timely diagnosis and treatment decisions. Veterinary point-of-care diagnostics include blood analyzers, imaging and testing devices, infectious disease tests, and other rapid diagnostic technologies used for companion animals and livestock.
Download a Free Sample To learn more about this report,
Growing Adoption of AI-Powered Point-of-Care Diagnostic Analyzers
The veterinary point of care diagnostics market is increasingly integrating artificial intelligence, automation, and advanced imaging into portable diagnostic analyzers. AI-enabled systems can assist with hematology, cytology, imaging, and other diagnostic workflows while delivering results directly within veterinary clinics. This reduces dependence on centralized laboratories and helps veterinarians make faster treatment decisions, particularly where staffing and diagnostic expertise are limited.
In March 2026, Zoetis announced that its VetScan OptiCell cartridge-based hematology analyzer was named a Best New Companion Animal Product in the S&P Global Animal Health 2025 Awards. The system combines microfluidics and AI to provide complete blood count analysis within minutes at the point of care, highlighting the industry's shift toward automated, AI-enabled veterinary diagnostics.
Increasing Expansion of Rapid and Multi-Parameter Testing at Veterinary Clinics
Another important trend is the expansion of in-clinic diagnostic menus that allow veterinarians to perform multiple tests rapidly without sending samples to external laboratories. Manufacturers are adding new assays for endocrine disorders, infectious diseases, hematology, and other conditions to existing point-of-care platforms. This development is supporting veterinary point of care diagnostics market growth by improving diagnostic turnaround times and enabling treatment decisions during the same clinical visit.
In June 2025, IDEXX Laboratories launched the Catalyst Cortisol Test for its Catalyst platform, providing real-time quantitative cortisol measurements to support the diagnosis and management of Addison's disease and Cushing's syndrome in dogs. The launch marked the third expansion of the Catalyst testing menu within less than a year, demonstrating the industry's focus on expanding on-site diagnostic capabilities.
Growing Demand for Rapid Veterinary Diagnosis
Veterinary clinics increasingly need diagnostic results quickly so veterinarians can make treatment decisions during the same consultation. Point-of-care systems can provide information on blood chemistry, hematology, infectious diseases, coagulation, and other conditions without requiring every sample to be sent to an external laboratory. Faster testing can support earlier intervention and improve workflow efficiency in companion-animal and livestock settings. These developments are strengthening veterinary point of care diagnostics market demand as veterinary practices seek convenient diagnostic solutions that can be used close to the patient.
In March 2026, IDEXX expanded its in-house diagnostic capabilities with the Catalyst One Chemistry Analyzer, designed to provide veterinary teams with rapid chemistry and electrolyte results during patient visits.
High Equipment Costs and Need for Skilled Operation
Veterinary point-of-care diagnostic systems can require significant investment in analyzers, cartridges, reagents, maintenance, quality control, and staff training. Smaller veterinary practices may find it difficult to justify specialized equipment when test volumes are limited. These factors influence the veterinary point of care diagnostics market analysis because providers must evaluate equipment utilization, consumable costs, workflow benefits, and long-term maintenance. Diagnostic accuracy can also depend on appropriate sample collection, handling, calibration, quality control, and interpretation, meaning point-of-care technology does not completely eliminate the need for trained veterinary professionals.
In April 2026, Zoetis highlighted its Vetscan Imagyst platform as a cloud-enabled diagnostic system that combines veterinary testing with specialist interpretation and AI capabilities, illustrating the broader technology and service infrastructure increasingly required for advanced point-of-care diagnostics.
Expansion of AI-Enabled and Multiparameter Diagnostics
Artificial intelligence, digital imaging, portable analyzers, and connected diagnostic platforms are creating opportunities to expand veterinary point-of-care testing. AI can assist with image interpretation and screening, while multiparameter systems can provide several measurements from a single patient sample. Cloud connectivity can also allow veterinary teams to share diagnostic information with specialists and integrate results into digital patient records. These developments are shaping veterinary point of care diagnostics market trends toward connected, automated, and decision-support-oriented testing systems that can improve diagnostic accessibility in clinics and other veterinary settings.
In June 2026, Zoetis expanded Vetscan Imagyst AI-powered diagnostic capabilities with new gastrointestinal testing designed to provide veterinary teams with automated parasite screening support from digital fecal images.
Maintaining Diagnostic Accuracy Across Diverse Veterinary Conditions
Veterinary point-of-care diagnostics must deliver reliable results across different species, breeds, ages, sample types, and clinical conditions. Biological differences between animals can make diagnostic interpretation more complex than in human medicine. Devices also need to perform consistently in clinics with varying levels of laboratory infrastructure and technical expertise. These requirements remain important for the veterinary point of care diagnostics market report because inaccurate or poorly interpreted results can delay appropriate treatment. Manufacturers therefore need robust validation, quality control, user-friendly workflows, and clear clinical interpretation support.
In February 2026, the U.S. FDA's Center for Veterinary Medicine continued emphasizing the importance of validated diagnostic methods and appropriate analytical performance for veterinary diagnostic products, highlighting the need for reliable testing before clinical use.
Companion Animal Segment Dominated the Market with 64.8% Share in 2025
The strong position of companion animals reflects growing demand for accessible and timely veterinary diagnostics. Pet owners are increasingly seeking preventive care and rapid diagnostic evaluation, encouraging veterinary practices to adopt point-of-care testing that can support faster clinical decision-making.
Request Customizationto receive a tailored report.
Consumables, Reagents, and Kits Segment Dominated the Market with 68.4% Share in 2025
The widespread use of consumables, reagents, and diagnostic kits supports their leading position in veterinary point-of-care diagnostics. These products are routinely required for testing and are replenished as diagnostic procedures are performed, creating consistent demand across veterinary settings.
Blood/Plasma/Serum Segment Dominated the Market with 54.7% Share in 2025
Blood, plasma, and serum samples are widely used for veterinary diagnostic testing because they can provide information across multiple clinical conditions. Their broad applicability in routine examinations and disease assessment continues to support their prominent position.
The virology segment is Expected to Grow at the Fastest CAGR of 10.15% During the Forecast Period
Increasing attention to viral diseases in animal populations is supporting demand for rapid and accessible virology testing. Point-of-care diagnostic capabilities can help veterinarians identify infections more efficiently and support timely treatment and disease-management decisions.
Infectious Disease Segment Dominated the Market with 52.8% Share in 2025
The high share of infectious disease testing reflects the importance of rapid identification and management of infections in veterinary care. Point-of-care diagnostics can provide results closer to the time of consultation, helping veterinarians make faster clinical decisions.
Home Care Settings Segment is Expected to Grow at the Fastest CAGR of 10.6% During the Forecast Period
The expansion of home-based animal care is creating opportunities for convenient diagnostic testing outside traditional veterinary facilities. Greater emphasis on continuous monitoring and accessible pet healthcare is encouraging the use of point-of-care diagnostic solutions in home care environments.
Speak to an Analystto discuss market opportunities.
The North American veterinary point of care diagnostics market accounted for 40.5% of the global market, reaching USD 0.93 billion in 2025. The region holds the largest market share, supported by advanced veterinary healthcare infrastructure, high pet healthcare spending, increasing adoption of rapid diagnostic technologies, and growing demand for convenient testing at veterinary clinics.
The United States represents a major market in North America. Its established veterinary healthcare infrastructure, large companion animal population, and increasing adoption of rapid diagnostic solutions continue to support market growth.
Canada's developed veterinary healthcare system, growing pet ownership, and increasing use of advanced diagnostic technologies continue to support regional market development.
Unlock Regional Insightsto access country-level data, & regional trends.
The Asia Pacific veterinary point of care diagnostics market accounted for 22.6% of the global market, reaching USD 0.52 billion in 2025, and is projected to grow at the fastest CAGR of 11.25% during the forecast period. Increasing pet ownership, expanding veterinary infrastructure, rising animal healthcare expenditure, and growing adoption of rapid diagnostic technologies are driving regional market development.
China represents a major market within the Asia Pacific. Rising companion animal ownership, expanding veterinary services, and increasing awareness of animal healthcare continue to support demand for point of care diagnostic solutions.
Japan's established veterinary healthcare system, high pet healthcare awareness, and increasing demand for convenient diagnostic testing continue to support market growth.
India's expanding veterinary healthcare infrastructure, growing companion animal population, and increasing awareness of animal disease diagnosis continue to create opportunities for point of care diagnostics.
The European veterinary point of care diagnostics market accounted for 27.2% of the global market, reaching USD 0.63 billion in 2025, and is projected to grow at a CAGR of 8.95% during the forecast period. Growing companion animal healthcare expenditure, increasing veterinary clinic adoption of rapid testing, and rising awareness of preventive animal healthcare continue to support regional growth.
Germany represents a major European market. Its established veterinary care infrastructure, strong pet healthcare sector, and increasing demand for efficient diagnostic testing continue to support market development.
The United Kingdom's developed veterinary services sector, growing emphasis on animal health, and increasing adoption of rapid diagnostic technologies continue to create opportunities for market growth.
Latin America's veterinary point of care diagnostics market accounted for 5.8% of the global market, reaching USD 0.13 billion in 2025, and is expected to grow at a CAGR of 9.15% during the forecast period. Expanding veterinary services, increasing pet ownership, and growing demand for accessible and rapid animal diagnostics continue to support regional market development.
Brazil represents a major regional market. Its expanding veterinary healthcare sector, growing pet population, and increasing demand for rapid diagnostic testing continue to support market growth.
The Middle East & Africa veterinary point of care diagnostics market accounted for 3.9% of the global market, reaching USD 0.09 billion in 2025, and is anticipated to grow at a CAGR of 8.45% during the forecast period. Improvements in veterinary healthcare infrastructure, rising pet ownership, and increasing awareness of animal health continue to support regional market expansion.
The UAE's developing veterinary healthcare infrastructure, increasing pet ownership, and growing demand for advanced animal healthcare services continue to support point of care diagnostics adoption.
Saudi Arabia's expanding veterinary services, growing focus on animal health, and increasing demand for modern diagnostic technologies continue to create opportunities for market development.
The global veterinary point of care diagnostics market is highly competitive, with leading animal health, veterinary diagnostics, medical technology, and laboratory equipment companies competing through blood chemistry analyzers, hematology analyzers, immunoassay systems, urinalysis solutions, molecular diagnostics, infectious disease testing, and portable diagnostic instruments. The major players in the market include IDEXX Laboratories, Zoetis, Virbac, Heska Corporation, Thermo Fisher Scientific Inc., Neogen Corporation, Mindray, Esaote SpA, FUJIFILM Corporation, Woodley Equipment Company Ltd., and others.
Industry participants are focusing on developing rapid, accurate, portable, and user-friendly diagnostic systems that enable veterinarians to obtain test results directly within clinics and animal care facilities. Companies are investing in automated analyzers, immunodiagnostics, molecular testing, digital imaging, connected diagnostic platforms, and cloud-based veterinary data management. Increasing pet ownership, growing expenditure on companion animal healthcare, rising prevalence of veterinary diseases, demand for faster clinical decision-making, and increasing adoption of preventive animal healthcare are encouraging veterinary practices to expand their point-of-care diagnostic capabilities.
IDEXX Laboratories is one of the leading companies in the global veterinary point of care diagnostics market, providing diagnostic instruments, consumables, laboratory services, and software solutions for companion animal and other veterinary practices. Its portfolio includes hematology and chemistry analyzers, immunoassays, urinalysis systems, infectious disease testing, and connected diagnostic technologies designed to support rapid clinical decision-making.
Customize This Report to Match Your Strategic Objectives
Author's Details
Senior Research Associate
Dhanshee Bhapkar is a healthcare research professional with 4+ years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.
Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.
Veterinary Pharmacovigilance Market Size, Share, 2034
Pet Mobility Aids Market Size, Share, Growth, Forecast, 2034
Veterinary Ultrasound Market Size, Share, Growth, Analysis, 2034
Veterinary Ventilators Market Size, Share, Growth, Analysis, 2034
Veterinary Anesthesia Equipment Market Size, Share, Growth, 2034
Equine Health Market Size, Share, Growth, Report, 2034
We are featured on:
sales@straitsresearch.com